Trends and emerging new models for pharma CRO partnerships

SMi’s 4th annual Managing Partnerships with CROs taking place on the 3rd & 4th October London will look to focus on five main areas: optimising interaction between sponsors and CROs, developing and executing strategic partnership models, partner selection, risk management and improving communication.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend

London (PRWEB UK) 25 September 2012

SMi is pleased to confirm Andrew Huxley, Regional Director of Clinical Operations, Eli Lilly Asia Pacific as a speaker at their upcoming Partnerships with CROs conference

He has been responsible for leading a new functional sourcing model and organisational change which is intended to provide improved sense of partnership and customer focus. He will be presenting on how to choose the right CRO for partnership as well as how to evaluate your own processes and requirements before choosing a partner, approach to asses a potential partner, developing an in-depth and thorough CMO/CRO questionnaire and strategies for short listing the number of potential companies

This event will provide delegates with a comprehensive overview and analysis of outsourcing in the pharmaceutical sector, offering the unique opportunity to hear from representatives from Pharma, CRO and Academia with an emphasis creating strong and successful partnerships between all parties. Attending will enable you to:

Learn from industry specialists the current issues facing those working within sponsor CRO relationships.

Understand what causes breakdown in relationships and ways to prevent this through real case studies.

Hear from speakers on both sides of the relationship, and their strategies for developing successful partnerships.

Discuss the strategic rationale for clinical development outsourcing among the large pharmaceutical companies


  • Sonal Patel
    SMi Group Ltd
    0207 827 6106
Follow us on: Contact's Twitter